Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000205645 | SCV000259427 | likely benign | Long QT syndrome | 2023-11-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345730 | SCV002650484 | uncertain significance | Cardiovascular phenotype | 2022-09-12 | criteria provided, single submitter | clinical testing | The p.R1803Q variant (also known as c.5408G>A), located in coding exon 42 of the CACNA1C gene, results from a G to A substitution at nucleotide position 5408. The arginine at codon 1803 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |